PF-06838435 (formerly SPK-9001) clinical trials

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

This study looks at a new treatment called PF-06838435 for people with haemophilia B. It checks if the treatment is safe and works well over a long time. It also explores a higher dose for new participants.